PortfoliosLab logoPortfoliosLab logo
PVLA vs. MSFT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

PVLA vs. MSFT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Palvella Therapeutics, Inc (PVLA) and Microsoft Corporation (MSFT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, PVLA achieves a 13.38% return, which is significantly higher than MSFT's -22.33% return.


PVLA

1D
-0.13%
1M
4.11%
YTD
13.38%
6M
18.36%
1Y
426.53%
3Y*
5Y*
10Y*

MSFT

1D
1.80%
1M
-10.66%
YTD
-22.33%
6M
-22.85%
1Y
-22.44%
3Y*
4.54%
5Y*
7.88%
10Y*
23.85%
*Multi-year figures are annualized to reflect compound growth (CAGR)

PVLA vs. MSFT - Yearly Performance Comparison


2026 (YTD)20252024
PVLA
Palvella Therapeutics, Inc
13.38%772.25%-8.27%
MSFT
Microsoft Corporation
-22.33%15.58%-5.76%

Correlation

The correlation between PVLA and MSFT is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.08

Correlation (All Time)
Calculated using the full available price history since Dec 16, 2024

0.07

Fundamentals

Market Cap

PVLA:

$1.34B

MSFT:

$2.78T

EPS

PVLA:

-$3.75

MSFT:

$16.79

PB Ratio

PVLA:

47.72

MSFT:

6.72

Total Revenue (TTM)

PVLA:

$0.00

MSFT:

$318.27B

Gross Profit (TTM)

PVLA:

$0.00

MSFT:

$217.41B

EBITDA (TTM)

PVLA:

-$14.75M

MSFT:

$200.96B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PVLA vs. MSFT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PVLA
PVLA Risk / Return Rank: 9797
Overall Rank
PVLA Sharpe Ratio Rank: 9999
Sharpe Ratio Rank
PVLA Sortino Ratio Rank: 9797
Sortino Ratio Rank
PVLA Omega Ratio Rank: 9595
Omega Ratio Rank
PVLA Calmar Ratio Rank: 9999
Calmar Ratio Rank
PVLA Martin Ratio Rank: 9898
Martin Ratio Rank

MSFT
MSFT Risk / Return Rank: 1212
Overall Rank
MSFT Sharpe Ratio Rank: 88
Sharpe Ratio Rank
MSFT Sortino Ratio Rank: 1111
Sortino Ratio Rank
MSFT Omega Ratio Rank: 1111
Omega Ratio Rank
MSFT Calmar Ratio Rank: 1717
Calmar Ratio Rank
MSFT Martin Ratio Rank: 1111
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PVLA vs. MSFT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Palvella Therapeutics, Inc (PVLA) and Microsoft Corporation (MSFT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


PVLAMSFTDifference
Sharpe ratioReturn per unit of total volatility

+6.19

Sortino ratioReturn per unit of downside risk

+5.57

Omega ratioGain probability vs. loss probability

1.54

0.86

+0.68

Calmar ratioReturn relative to maximum drawdown

13.82

-0.66

+14.49

Martin ratioReturn relative to average drawdown

31.14

-1.32

+32.46

PVLA vs. MSFT - Sharpe Ratio Comparison

The current PVLA Sharpe Ratio is 5.32, which is higher than the MSFT Sharpe Ratio of -0.87. The chart below compares the historical Sharpe Ratios of PVLA and MSFT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

PVLA vs. MSFT - Drawdown Comparison

The maximum PVLA drawdown since its inception was -31.48%, smaller than the maximum MSFT drawdown of -69.38%. Use the drawdown chart below to compare losses from any high point for PVLA and MSFT.


Loading charts...

Drawdown Indicators


PVLAMSFTDifference

Max Drawdown

Largest peak-to-trough decline

-31.48%

-69.38%

+37.90%

Max Drawdown (1Y)

Largest decline over 1 year

-31.11%

-33.91%

+2.80%

Max Drawdown (3Y)

Largest decline over 3 years

-33.91%

Max Drawdown (5Y)

Largest decline over 5 years

-37.15%

Max Drawdown (10Y)

Largest decline over 10 years

-37.15%

Current Drawdown

Current decline from peak

-19.99%

-30.58%

+10.59%

Average Drawdown

Average peak-to-trough decline

-11.16%

-21.79%

+10.63%

Ulcer Index

Depth and duration of drawdowns from previous peaks

13.79%

17.08%

-3.29%

Volatility

PVLA vs. MSFT - Volatility Comparison

Palvella Therapeutics, Inc (PVLA) has a higher volatility of 19.68% compared to Microsoft Corporation (MSFT) at 11.34%. This indicates that PVLA's price experiences larger fluctuations and is considered to be riskier than MSFT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PVLAMSFTDifference

Volatility (1M)

Calculated over the trailing 1-month period

19.68%

11.34%

+8.34%

Volatility (6M)

Calculated over the trailing 6-month period

61.91%

22.94%

+38.97%

Volatility (1Y)

Calculated over the trailing 1-year period

80.85%

26.02%

+54.83%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

82.11%

26.79%

+55.32%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

82.11%

27.09%

+55.02%

Dividends

PVLA vs. MSFT - Dividend Comparison

PVLA has not paid dividends to shareholders, while MSFT's dividend yield for the trailing twelve months is around 0.95%.


PositionTTM20252024202320222021202020192018201720162015
MSFT
Microsoft Corporation
0.95%0.70%0.73%0.74%1.06%0.68%0.94%1.20%1.69%1.86%2.37%2.33%
PVLA
Palvella Therapeutics, Inc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

PVLA vs. MSFT - Financials Comparison

This section allows you to compare key financial metrics between Palvella Therapeutics, Inc and Microsoft Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober20260
82.89B
(PVLA) Total Revenue
(MSFT) Total Revenue
Values in USD except per share items

Frequently Asked Questions


PVLA and MSFT have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

PVLA has higher volatility (19.68%) compared to MSFT (11.34%). In terms of maximum drawdown, PVLA dropped -31.48% vs MSFT's -69.38%.

PVLA currently has the higher Sharpe Ratio (5.32 vs -0.87), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for PVLA and MSFT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer